| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 01/11/2007 | US20070011759 Vector mediated organelle transfection |
| 01/11/2007 | US20070011754 Lysosomal proteins produced in the milk of transgenic animals |
| 01/11/2007 | US20070010662 VGF fusion polypeptides |
| 01/11/2007 | US20070010660 G-CSF Conjugates |
| 01/11/2007 | US20070010659 solubility of the variant is improved by at least 3-fold relative to residues 110-244 of human adiponectin; increased soluble expression and stability, lower immunogenicity, and improved pharmacokinetics and/or pharmacodynamics |
| 01/11/2007 | US20070010658 Trimeric binding proteins for trimeric cytokines |
| 01/11/2007 | US20070010657 Cytoplasmic dynein heavy chain 1 genes, expression products, non-human animal model uses in human neurological diseases |
| 01/11/2007 | US20070010656 Novel exendin agonist compounds |
| 01/11/2007 | US20070010655 Stationary phases and a purification process using the stationary phases |
| 01/11/2007 | US20070010547 Method for modulating gene expression in epithelial cells |
| 01/11/2007 | US20070010546 Method for enhancing epithelial cell proliferation and uses thereof |
| 01/11/2007 | US20070010502 Synergistic mixture containing pyrimidopyrimidine compound with another active material |
| 01/11/2007 | US20070010483 Glucocerebroside treatment of liver disorders |
| 01/11/2007 | US20070010476 Therapy and diagnosis of conditions related to telomere length and/or telomerase activity |
| 01/11/2007 | US20070010473 Nucleic acid ligands to integrins |
| 01/11/2007 | US20070010472 Oligonucleotide compositions and their use to induce differentiation of cells |
| 01/11/2007 | US20070010468 Methods and compositions for the inhibition of stat5 in prostate cancer cells |
| 01/11/2007 | US20070010457 Caspase inhibitors and uses thereof |
| 01/11/2007 | US20070010456 Therapeutic agents for low HDL-cholesterolemia |
| 01/11/2007 | US20070010455 Serine protease inhibition via 1-{[1-(2-Methoxycarbonylamino-3,3-dimethyl-butyryl)-4-(7-methoxy-2-phenyl-quinolin-4-yloxy)-pyrrolidine-2-carbonyl]-amino}-2-vinyl-cyclopropanecarboxylic acid |
| 01/11/2007 | US20070010454 Method for treating tumor cells resulting in minimal liver toxicity |
| 01/11/2007 | US20070010453 Prodrugs of GABA analogs, compositions and uses thereof |
| 01/11/2007 | US20070010452 Methionine aminopeptidase-2 inhibitors and methods of use thereof |
| 01/11/2007 | US20070010451 Method of protecting cells against damage and pharmaceutical composition comprising leumorphin |
| 01/11/2007 | US20070010450 Hypertension, salt dependent high blood pressure, hepatic edema and liver cirrhosis; administering a hypotensive, antiedemic, and anticholesterol polypeptide that activates the guanylate cyclase receptor |
| 01/11/2007 | US20070010449 Administering Nematode-Extracted Anticoagulant Protein to treat viral hemorrhagic fever caused by a Filovirus, Arenavirus, Bunyavirus or Flavirus. |
| 01/11/2007 | US20070010448 Drug targets in Candida albicans |
| 01/11/2007 | US20070010447 Methods and compounds for the treatment of mucus hypersecretion |
| 01/11/2007 | US20070010446 As antiinflammatory agent alone or in combinaton; side effect reduction of glucocorticoid treatment; acute or chronic inflammation such as autoimmune disease, allergies, asthma, chronic obstructive pulmonary disease, psoriasis, dermatitis, Inflammatory Bowel disease |
| 01/11/2007 | US20070010445 Administration of hypocretin-1 for treatment of narcolepsy |
| 01/11/2007 | US20070010444 Novel mediator of neurotransmitter and psychostimulant responses |
| 01/11/2007 | US20070010443 Monitoring and modulating HGF/HGFR activity |
| 01/11/2007 | US20070010442 Inhibitor of vascular endothelial cell growth factor |
| 01/11/2007 | US20070010441 A purified binding protein bound to an imaging agent, a drug, or an antigen, and which specifically binds to the GIT receptor HPT1, hPEPT1, D2H, or hSI; time-release agents; improved bioavailability; receptor binding assay; drug screening |
| 01/11/2007 | US20070010440 Local treatment of bone defects |
| 01/11/2007 | US20070010439 Production of human parathyroid hormone from microorganisms |
| 01/11/2007 | US20070010438 Tumor treatment using beta-sheet peptides and radiotherapy |
| 01/11/2007 | US20070010437 Amino acid based compositions for the treatment of pathological conditions distinguised by insufficient mitochondrial function |
| 01/11/2007 | US20070010436 Remedy for cardiomyopathy |
| 01/11/2007 | US20070010435 Method for treating amyloid disease |
| 01/11/2007 | US20070010434 Novel compositions and methods for the treatment of immune related diseases |
| 01/11/2007 | US20070010433 Use of compounds capable of inhibiting the proteolytic processing of semaphorins for prevention, treatment, diagnosis and prognosis of an invasive disease |
| 01/11/2007 | US20070010432 Heat shock protein 90 activator |
| 01/11/2007 | US20070010431 single unit dosage; surfactant and inhibitors of HCV protease or cathepsin; good dissolution for bioabsorption; N-[3-amino-1-(cyclobutylmethyl)-2,3-dioxopropyl]-3-[2-[[[(1,1-dimethylethyl)amino]carbonyl]amino]-3,3-dimethyl-1-oxobutyl]-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide |
| 01/11/2007 | US20070010430 Proteoglycan isolated from cartilaginous fish and process for producing the same |
| 01/11/2007 | US20070010429 Phospholipid formulations and uses thereof in lung disease detection and treatment |
| 01/11/2007 | US20070010428 Inhibitors of signal transduction and activator of transcription 3 |
| 01/11/2007 | US20070010427 Toxic metal-protein (cycsteines) complex targeted for cells/tissues to enrich the site with metal ligand; administering a dithiocarbonyl having greater affinity for the metal and permeability of the membrane to release the metal inside the cell; antitumor, -carcinogenic agents; apoptosisdeath |
| 01/11/2007 | US20070010426 Composition for preventing and treating cardiovascular disorders |
| 01/11/2007 | US20070010425 Pharmaceutical compositions and methods for insulin treatment |
| 01/11/2007 | US20070010424 Propylene glycol-containing peptide formulations which are optimal for production and for use in injection devices |
| 01/11/2007 | US20070010423 Compositions comprising balaglitazone and further antidiabetic compounds |
| 01/11/2007 | US20070010422 Improved bioavailability; for oral and intracolonic administration |
| 01/11/2007 | US20070009988 Leucine aminopeptidase polypeptide, carboxypeptidases polypeptide; dermatophyte; degradation, hydrolysis or maturation of polypeptide substrate; Exonuclease X of Escherichia coli ( EXOX protein); fungicides; dipeptidyl peptidase IV |
| 01/11/2007 | US20070009986 Compositions for modulating immune cell activity and methods for detection thereof |
| 01/11/2007 | US20070009972 Epidermal growth factor receptor polypeptides and antibodies |
| 01/11/2007 | US20070009971 for inhibiting apoptosis in mammalian cells; zinc finger domains; consensus sequences; genetic engineering; for treating AIDS, alzheimer's disease, parkinson's disease, amyotrophic lateral sclerosis (ALS), retinitis pigmentosa, autoimmune diseases |
| 01/11/2007 | US20070009967 Methods for shp1 mediated neuroprotection |
| 01/11/2007 | US20070009964 competing with natural OX40L for blocking OX40R-mediated cell signaling in the prophylaxis and/or treatment of diseases related to activated T cells |
| 01/11/2007 | US20070009956 Arginine hydrochloride enhances chaperone-like activity of alpha crystallin |
| 01/11/2007 | US20070009952 detecting susceptibility for basement membrane disease such as congenital nephrotic syndromes of the Finnish type (NPHS1); proteinuria; detecting the presence or absence of a mutation in the coding region of the gene for NPHS1 |
| 01/11/2007 | US20070009936 mTOR kinase-associated proteins |
| 01/11/2007 | US20070009926 Biomarkers of resistance to infections in humans and biological applications thereof |
| 01/11/2007 | US20070009921 Fragments of virus protein 2 or 3 of polyoma virus as vehicles for active substances |
| 01/11/2007 | US20070009918 Methods and compositions for regulating T cell subsets by modulating transcription factor activity |
| 01/11/2007 | US20070009916 Guanosine triphosphate-binding protein coupled receptors |
| 01/11/2007 | US20070009888 Compositions, splice variants and methods relating to breast specific genes and proteins |
| 01/11/2007 | US20070009609 Solid compositions containing combinations of lactoferrin, colostrum, and citrus pectin |
| 01/11/2007 | US20070009605 Encapsulation of water soluble peptides |
| 01/11/2007 | US20070009604 Such as proteins or polypeptides via anti-solvent under supercritical conditions; water solubility; Rapid Expansion of Supercritical Solutions or Gas Anti-solvent precipitation |
| 01/11/2007 | US20070009583 comprises absorber materials and proteolytic enzymes contained in liposomes, for debridement of necrotic and non-viable tissues in injuries, by controlled or sustained release of proteolytic enzymes to the injury |
| 01/11/2007 | US20070009578 Haemostatic composition comprising hyaluronic acid |
| 01/11/2007 | US20070009575 Novel use of antisecretory factor |
| 01/11/2007 | US20070009571 Novel haptotactic peptides |
| 01/11/2007 | US20070009569 Delivery device for topical, oral, intravenous, intraperitoneal, intramuscular, transdermal, nasal, or iontophoretic administration coated with a RNAIII inhibiting heptapeptide of the sequence Tyr-X2-Pro-X1-Thr-Asn-Phe where X1 is Cys, Trp or Ile, and X2 is Lys or Ser; antibiotic resistance |
| 01/11/2007 | US20070009567 Methods and compositions for the treatment and prevention of staphylococcal infections |
| 01/11/2007 | US20070009566 Method and apparatus for treating bacterial infections in devices |
| 01/11/2007 | US20070009554 Biologically active hemagglutinin from type a clostridium botulinum and methods of use |
| 01/11/2007 | US20070009552 Simultaneous protection against each of the four dengue viruses, thereby precluding the possibility of developing the more serious illnesses dengue hemorrhagic fever/dengue shock syndrome (DHF/DSS), which occur in humans during secondary infection with a heterotypic wild-type dengue virus |
| 01/11/2007 | US20070009550 Postweaning multisystemic wasting syndrome and porcine circovirus from pigs |
| 01/11/2007 | US20070009546 Isolated nucleic acid; screening for antibacterial compounds |
| 01/11/2007 | US20070009543 Protein involved in ovarian cancer |
| 01/11/2007 | US20070009538 Expression and export of angiogenesis inhibitors as immunofusins |
| 01/11/2007 | US20070009533 Treatment of cancer patients exhibiting activation of the P-glycoprotein efflux pump mechanism |
| 01/11/2007 | US20070009525 Human Endokine Alpha and Methods of Use |
| 01/11/2007 | US20070009524 Methods of treating inflammation associated with viral infection with anti-tnf antibodies |
| 01/11/2007 | US20070009520 Osteoclastogenesis inhibitory factor-binding molecule (OBM) specific immunoglobulin for use inhibiting osteoclast inhibitory factor (OCIF) binding activity and treating bone disorders |
| 01/11/2007 | US20070009517 Method of inducing immune tolerance |
| 01/11/2007 | US20070009514 Prostaglandin receptor ep1 |
| 01/11/2007 | US20070009513 Novel method of screening |
| 01/11/2007 | US20070009512 Recombinant bivalent monospecific immunoglobulin having at least two variable fragments of heavy chains of an immunoglobulin devoid of light chains |
| 01/11/2007 | US20070009507 Fibrin citrulline derivatives and their use for diagnosing or treating rheumatoid arthritis |
| 01/11/2007 | US20070009506 Methods for production of recombinant urokinase |
| 01/11/2007 | US20070009505 Composition and system for wound decontamination |
| 01/11/2007 | US20070009504 Pro-apoptotic agents |
| 01/11/2007 | US20070009503 Antibiotic, Compositions Containing the Antibiotic, and Methods for Administering the Antibiotic and/or Said Compositions to Livestock |
| 01/11/2007 | US20070009501 Squamous cell carcinoma antigens and use therefor |
| 01/11/2007 | US20070009499 Myoblast treatment of diseased or weakened organs |
| 01/11/2007 | US20070009498 Nucleic acid constructs useful for glucose regulated production of human insulin in somatic cell lines |
| 01/11/2007 | US20070009489 Mutant Salmonella species with genetically engineered MSBB gene, expresses altered lipid, has reduced inductino of tumor necrosis factor and increased sensitivity to chelating agents; as antitumor agent |